Sage Journals: Discover world-class research

Open access

Research article

First published 2025-7

Rimegepant safety and patient-reported outcomes among triptan-naïve,triptan-using,and triptan-failure participants: Subgroup analysis of an open-label,multicenter study

Jessica Ailani, Jelena Pavlovic, Glenn C Pixton [...]

Cephalalgia

Free access

Research article

First published 2022-1

Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study

Uwe Reuter, John H Krege, Louise Lombard [...]

Cephalalgia

Free access

Research article

First published 2013-8

Triptan nonresponders: Do they exist and who are they?

Michele Viana, Armando A Genazzani, Salvatore Terrazzino [...]

Cephalalgia

Open access

Research article

First published 2024-9

Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study

Robyn-Jenia Wilcha, Peter J. Goadsby

Cephalalgia

Free access

Research article

First published 2010-7

Quantifying the return of headache in triptan-treated migraineurs: An observational study

Fred Sheftell, Mary Almas, Randall Weeks [...]

Cephalalgia

Open access

Research article

First published 2025-11

Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized,double-blind,placebo-controlled phase 4 trial

Messoud Ashina, Peter McAllister, Charly Gaul [...]

Cephalalgia

Free access

Research article

First published 2008-1

Identification of Negative Predictors of Pain-Free Response to Triptans: Analysis of the Eletriptan Database

H-C Diener, DW Dodick, PJ Goadsby [...]

Cephalalgia

Open access

Brief report

First published 2024

Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations

Andrea Burgalassi, Giulia Vigani, Alberto Boccalini [...]

Cephalalgia Reports

Open access

Research article

First published 2025

Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world,prospective,multicentric study (DART study)

Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2026

Reasons for discontinuation of CGRP antibody therapy: Insights from a retrospective real-world cohort study

Lennart Menzel, Dominik Fiebelkorn, Vincent Breunung [...]

Cephalalgia Reports

Search results